Literature DB >> 25100564

Trim32 facilitates degradation of MYCN on spindle poles and induces asymmetric cell division in human neuroblastoma cells.

Hideki Izumi1, Yasuhiko Kaneko1.   

Abstract

Asymmetric cell division (ACD) is a physiologic process during development and tissue homeostasis. ACD produces two unequal daughter cells: one has stem/progenitor cell activity and the other has potential for differentiation. Recent studies showed that misregulation of the balance between self-renewal and differentiation by ACD may lead to tumorigenesis in Drosophila neuroblasts. However, it is still largely unknown whether human cancer stem-like cells exhibit ACD or not. Here, using human neuroblastoma cells as an ACD model, we found that MYCN accumulates at spindle poles by GSK-3β phosphorylation during mitosis. In parallel, the ACD-related ubiquitin ligase Trim32 was recruited to spindle poles by CDK1/cyclin B-mediated phosphorylation. Trim32 interacted with MYCN at spindle poles during mitosis, facilitating proteasomal degradation of MYCN at spindle poles and inducing ACD. Trim32 also suppressed sphere formation of neuroblastoma-initiating cells, suggesting that the mechanisms of ACD produce differentiated neuroblastoma cells that will eventually die. Thus, Trim32 is a positive regulator of ACD that acts against MYCN and should be considered as a tumor-suppressor candidate. Our findings offer novel insights into the mechanisms of ACD and clarify its contributions to human tumorigenesis. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25100564     DOI: 10.1158/0008-5472.CAN-14-0169

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Upregulated Expression of TRIM32 Is Involved in Schwann Cell Differentiation, Migration and Neurite Outgrowth After Sciatic Nerve Crush.

Authors:  Yonghua Liu; Weijie Wu; Huiguang Yang; Zhengming Zhou; Xiaojian Zhu; Chi Sun; Yuxi Liu; Zhaohui Yu; Yuyan Chen; Youhua Wang
Journal:  Neurochem Res       Date:  2016-12-26       Impact factor: 3.996

2.  TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway.

Authors:  Zhao Chen; Lifang Tian; Li Wang; Xiaotao Ma; Fuqian Lei; Xianghui Chen; Rongguo Fu
Journal:  Inflammation       Date:  2021-11-16       Impact factor: 4.092

3.  Upregulated TRIM32 correlates with enhanced cell proliferation and poor prognosis in hepatocellular carcinoma.

Authors:  Xiaopeng Cui; Zhipeng Lin; Yuyan Chen; Xiaofei Mao; Wenkai Ni; Jinxia Liu; Huiling Zhou; Xiaohang Shan; Lingling Chen; Jiale Lv; Zhongyi Shen; Chengwei Duan; Baoying Hu; Runzhou Ni
Journal:  Mol Cell Biochem       Date:  2016-08-30       Impact factor: 3.396

4.  Drosophila TRIM32 cooperates with glycolytic enzymes to promote cell growth.

Authors:  Simranjot Bawa; David S Brooks; Kathryn E Neville; Marla Tipping; Md Abdul Sagar; Joseph A Kollhoff; Geetanjali Chawla; Brian V Geisbrecht; Jason M Tennessen; Kevin W Eliceiri; Erika R Geisbrecht
Journal:  Elife       Date:  2020-03-30       Impact factor: 8.140

5.  Trim32 suppresses cerebellar development and tumorigenesis by degrading Gli1/sonic hedgehog signaling.

Authors:  Minglei Wang; Wenqin Luo; Yu Zhang; Rong Yang; Xuefeng Li; Yanjing Guo; Chenlu Zhang; Ru Yang; Wei-Qiang Gao
Journal:  Cell Death Differ       Date:  2019-09-17       Impact factor: 15.828

6.  Quantitative ubiquitylome analysis and crosstalk with proteome/acetylome analysis identified novel pathways and targets of perifosine treatment in neuroblastoma.

Authors:  Min Jiang; Zhongyan Hua; Yudi Dong; Zhihui Liu; Carol J Thiele; Zhijie Li
Journal:  Transl Cancer Res       Date:  2018-12       Impact factor: 1.241

7.  TRIM32 is a novel negative regulator of p53.

Authors:  Juan Liu; Yu Zhu; Wenwei Hu; Zhaohui Feng
Journal:  Mol Cell Oncol       Date:  2014-12-01

8.  Symmetry breaking in human neuroblastoma cells.

Authors:  Hideki Izumi; Yasuhiko Kaneko
Journal:  Mol Cell Oncol       Date:  2014-12-31

Review 9.  Metabolic enzymes: key modulators of functionality in cancer stem-like cells.

Authors:  Bo-Wen Dong; Guang-Ming Qin; Yan Luo; Jian-Shan Mao
Journal:  Oncotarget       Date:  2017-02-21

10.  TRIM32 promotes cell proliferation and invasion by activating β-catenin signalling in gastric cancer.

Authors:  Changming Wang; Jiapeng Xu; Hongbing Fu; Yu Zhang; Xin Zhang; Dejun Yang; Zhenxin Zhu; Ziran Wei; Zunqi Hu; Ronglin Yan; Qingping Cai
Journal:  J Cell Mol Med       Date:  2018-08-05       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.